FTIOP
TEVA icon

Fiduciary Trust International of Pennsylvania’s Teva Pharmaceuticals TEVA Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-120,900
Closed -$2.6M – 338
2018
Q3 		$2.6M Sell
120,900
-7,100
-6% -$165K 0.11% 163
2018
Q2 		$3.11M Buy
128,000
+1,400
+1% +$28.6K 0.14% 145
2018
Q1 		$2.16M Hold
126,600
– – 0.1% 183
2017
Q4 		$2.4M Buy
126,600
+27,200
+27% +$409K 0.11% 178
2017
Q3 		$1.75M Buy
99,400
+3,165
+3% +$71.2K 0.08% 176
2017
Q2 		$3.2M Buy
96,235
+61,535
+177% +$1.9M 0.16% 152
2017
Q1 		$1.11M Sell
34,700
-475
-1% -$16.2K 0.08% 159
2016
Q4 		$1.27M Buy
+35,175
New +$1.4M 0.1% 142
2016
Q3 		– Sell
-23,894
Closed -$1.2M – 312
2016
Q2 		$1.2M Sell
23,894
-6,740
-22% -$359K 0.1% 150
2016
Q1 		$1.64M Sell
30,634
-3,233
-10% -$190K 0.14% 120
2015
Q4 		$2.22M Sell
33,867
-4,173
-11% -$258K 0.19% 114
2015
Q3 		$2.15M Sell
38,040
-9,000
-19% -$584K 0.2% 113
2015
Q2 		$2.78M Buy
47,040
+10,000
+27% +$617K 0.16% 142
2015
Q1 		$2.31M Buy
37,040
+1,100
+3% +$64K 0.15% 140
2014
Q4 		$2.07M Buy
35,940
+125
+0.3% +$6.96K 0.14% 141
2014
Q3 		$1.93M Buy
35,815
+175
+0.5% +$9.27K 0.13% 144
2014
Q2 		$1.87M Sell
35,640
-295
-0.8% -$15.1K 0.13% 145
2014
Q1 		$1.9M Buy
35,935
+1,449
+4% +$67K 0.14% 146
2013
Q4 		$1.38M Sell
34,486
-1,200
-3% -$47.3K 0.1% 162
2013
Q3 		$1.35M Sell
35,686
-1,400
-4% -$54.6K 0.11% 167
2013
Q2 		$1.45M Buy
+37,086
New +$1.44M 0.13% 159

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's TEVA Position: Q4 2018 in Review

Fiduciary Trust International of Pennsylvania sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 120,900 shares — an estimated $2.6M sold.

Fiduciary Trust International of Pennsylvania first reported a position in TEVA in Q2 2013 and held it in 21 quarters. The position peaked at $3.2M in Q2 2017. 552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • Fiduciary Trust International of Pennsylvania reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 120,900 Teva Pharmaceuticals shares in Q4 2018, an estimated $2.6M.
  • Fiduciary Trust International of Pennsylvania first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Fiduciary Trust International of Pennsylvania's Teva Pharmaceuticals position peaked at $3.2M in Q2 2017.
  • 552 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2018, filed 14 Jan 2019.